Avestar Capital »

Y Mabs Therapeutics shares owned by Avestar Capital

Quarter-by-quarter ownership of Y Mabs Therapeutics (YMAB) shares owned by Avestar Capital from 13F filings

Historical chart of Avestar Capital investment in Y Mabs Therapeutics

Tip: Access up to 7 years of quarterly data

All positions including Y Mabs Therapeutics held by Avestar Capital consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Y Mabs Therapeutics by Avestar Capital

Quarter filed Position value Share count Share price at filing
2023-12-31 $68k 10k 6.82
2023-09-30 $55k 10k 5.45
2023-06-30 $68k 10k 6.79

More positions owned by Avestar Capital

Alphabet Cap Stk Cl C (GOOG)
Apple (AAPL)
Spdr S&p 500 Etf Tr Tr Unit (SPY)
Invesco Actively Managed Etf Ultra Shrt Dur (GSY)
J P Morgan Exchange Traded F Ultra Shrt Inc (JPST)
Pgim Etf Tr Pgim Ultra Sh Bd (PULS)
First Tr Exchange-traded First Tr Enh New (FTSM)
Ssga Active Etf Tr Ult Sht Trm Bd (ULST)
Wisdomtree Tr Floatng Rat Trea (USFR)
Meta Platforms Cl A (META)
Ishares Tr Blackrock Ultra (ICSH)
Microsoft Corporation Put Option (MSFT)
Goldman Sachs Etf Tr Aces Ultra Shr (GSST)
Amazon (AMZN)
Invesco Exchange Traded Fd T S&p 500 Top 50 (XLG)

View all positions for Avestar Capital

Top funds holding Y Mabs Therapeutics

Vanguard Group
D. E. Shaw & Co
Caligan Partners
Goldman Sachs Group
Dimensional Fund Advisors
Jacobs Levy Equity Management
Charles Schwab Investment Management
Connor, Clark & Lunn Investment Management
Two Sigma Advisers
Soleus Capital Management
Citadel Advisors
Thomas Stevens, CFA"
Marshall Wace
Bank of New York Mellon
Rice Hall James & Associates

View all funds holding Y Mabs Therapeutics